Q2 FY2026 · ended Jun 30, 2026 · Revenue $12,161, -82.8% YoY · Filed Aug 12, 2026
Nexalin Technology, Inc. (NXL) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $12,161 and a net loss of $2.2 million.
Revenue
$12,161
-82.8% vs year-ago quarter
Net income
$-2.24M
-41.6% vs year-ago quarter
Operating cash flow
$-1.80M
-96.4% vs year-ago quarter
Free cash flow
—
EPS
$-0.11
-10.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
22.04M
+26.5% vs year-ago quarter
Net cash
—
Operating margin
-4202.5%
TTM
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- NXL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Houston, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1527352
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $12,161 | $14,950 | $171,895 | $18,149 | $70,588 |
| Operating income | -$2.2M | -$2.1M | -$2.4M | -$2.3M | -$1.6M |
| Net income | -$2.2M | -$2.1M | -$2.4M | -$2.3M | -$1.6M |
| Diluted EPS | -$0.11 | -$0.11 | -$0.13 | -$0.13 | -$0.10 |
| Operating cash flow | -$1.8M | -$1.7M | -$1.1M | -$1.5M | -$917,165 |
| Total assets | $3.0M | $3.7M | $4.6M | $5.1M | $6.6M |
| Total liabilities | $1.5M | $808,364 | $887,333 | $357,524 | $600,584 |
| Stockholders' equity | $1.5M | $2.9M | $3.7M | $4.8M | $6.0M |
| Cash and investments | $1.0M | $2.7M | $3.7M | $4.4M | $5.8M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 1, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 1, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Listing notice
|
Sep 28, 2026 | Sep 25, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 2, 2026 | Aug 28, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Aug 27, 2026 | Aug 26, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Aug 21, 2026 | Aug 21, 2026 |
All 204 Nexalin Technology, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.